Lai Wang's most recent trade in BeiGene Ltd - ADR was a trade of 1,028 American Depositary Shares done at an average price of $260 . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 260.00 per share. | 23 Jun 2025 | 1,028 | 0 (0%) | 0% | 260 | 267,280 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 266.40 per share. | 16 Jun 2025 | 1,177 | 470 (0%) | 0% | 266.4 | 313,558 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 251.37 per share. | 16 Jun 2025 | 470 | 0 (0%) | 0% | 251.4 | 118,142 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 162,565 | 162,565 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 86,359 | 1,058,304 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 250.71 per share. | 06 Jun 2025 | 600 | 802 (0%) | 0% | 250.7 | 150,425 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 253.19 per share. | 06 Jun 2025 | 300 | 300 (0%) | 0% | 253.2 | 75,956 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 255.30 per share. | 06 Jun 2025 | 300 | 0 (0%) | 0% | 255.3 | 76,590 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 251.89 per share. | 06 Jun 2025 | 202 | 600 (0%) | 0% | 251.9 | 50,882 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 69,251 | 990,171 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 258.73 per share. | 21 Feb 2025 | 1,782 | 400 (0%) | 0% | 258.7 | 461,058 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 254.82 per share. | 21 Feb 2025 | 1,327 | 3,673 (0%) | 0% | 254.8 | 338,149 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 255.86 per share. | 21 Feb 2025 | 575 | 3,098 (0%) | 0% | 255.9 | 147,117 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 256.70 per share. | 21 Feb 2025 | 479 | 2,619 (0%) | 0% | 256.7 | 122,957 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 258.18 per share. | 21 Feb 2025 | 437 | 2,182 (0%) | 0% | 258.2 | 112,826 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 260.17 per share. | 21 Feb 2025 | 400 | 0 (0%) | 0% | 260.2 | 104,067 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 220.35 per share. | 27 Sep 2024 | 5,000 | 0 (0%) | 0% | 220.4 | 1,101,774 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.80 per share. | 24 Jun 2024 | 1,062 | 2 (0%) | 0% | 159.8 | 169,708 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 161.00 per share. | 24 Jun 2024 | 2 | 0 (0%) | 0% | 161 | 322 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 153.75 per share. | 17 Jun 2024 | 841 | 0 (0%) | 0% | 153.8 | 129,305 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.42 per share. | 17 Jun 2024 | 485 | 1,141 (0%) | 0% | 159.4 | 77,321 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.00 per share. | 17 Jun 2024 | 478 | 1,626 (0%) | 0% | 159.0 | 76,001 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 159.90 per share. | 17 Jun 2024 | 300 | 841 (0%) | 0% | 159.9 | 47,971 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Sale of securities on an exchange or to another person at price $ 158.50 per share. | 17 Jun 2024 | 237 | 2,104 (0%) | 0% | 158.5 | 37,565 | American Depositary Shares |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 318,253 | 318,253 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Lai Wang | Global Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 168,935 | 1,768,962 (0%) | 0% | 0 | Ordinary Shares |